(MedPage Today) — The 9-valent human papillomavirus (HPV) vaccine was associated with a lower risk of HPV-related cancers in adolescent males and young men, according to a large retrospective cohort study.
Among males ages 9 to 26 years, those…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
